Trials / Unknown
UnknownNCT00955214
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
Impact of Paclitaxel-eluting Stent for Small Coronary Artery Disease
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Society for Advancement of Coronary Intervention Research · Network
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The utilization of paclitaxel-eluting coronary stents in small vessel diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of the Taxus Liberte™ Paclitaxel-Eluting Coronary Stent in small coronary arteries of ≤ 2.5 mm in the reference vessel diameter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TAXUS Liberté paclitaxel-eluting coronary stent system | diameter is 2.5mm |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-08-01
- Completion
- 2012-08-01
- First posted
- 2009-08-10
- Last updated
- 2010-06-10
Locations
23 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00955214. Inclusion in this directory is not an endorsement.